HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chin, K. V. Articles by Gottesman, M. M. Search for Related Content PubMed PubMed Citation Articles by Chin, K. V. Articles by Gottesman, M. M. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 1, 221-226, 01, 1990

Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells

KV Chin, S Tanaka, G Darlington, I Pastan and MM Gottesman
Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892.

The multidrug transporter, initially identified as a multidrug efflux pump responsible for resistance of cultured cells to natural product cytotoxic drugs, is normally expressed on the apical membranes of excretory epithelial cells in the liver, kidney, and intestine. This localization suggests that the multidrug transporter may have a normal physiological role in transporting cytotoxic compounds or metabolites. In the liver, hepatectomy or treatment with chemical carcinogens increases expression of the MDR1 gene which encodes the multidrug transporter. To evaluate conditions which increase MDR1 gene expression, we have investigated the induction of the MDR1 gene by physical and chemical environmental insults in the renal adenocarcinoma cell line HTB-46. There are two strong heat shock consensus elements in the major MDR1 gene promoter. Exposure of HTB-46 cells to heat shock, sodium arsenite, or cadmium chloride led to a 7- to 8-fold increase in MDR1 mRNA levels. MDR1 RNA levels did not change following glucose starvation or treatment with 2-deoxyglucose and the calcium ionophore A23187, conditions which are known to activate the expression of another family of stress proteins, the glucose-regulated proteins. The levels of the multidrug transporter, P-glycoprotein, as measured by immunoprecipitation, were also increased after heat shock and sodium arsenite treatment. This increase in the level of the multidrug transporter in HTB-46 cells correlated with a transient increase in resistance to vinblastine following heat shock and arsenite treatment. These results suggest that the MDR1 gene is regulatable by environmental stress.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. K. McCollum, C. J. TenEyck, B. Stensgard, B. W. Morlan, K. V. Ballman, R. B. Jenkins, D. O. Toft, and C. Erlichman P-Glycoprotein-Mediated Resistance to Hsp90-Directed Therapy Is Eclipsed by the Heat Shock Response Cancer Res., September 15, 2008; 68(18): 7419 - 7427. [Abstract] [Full Text] [PDF]

				R. Callaghan, E. Crowley, S. Potter, and I. D. Kerr P-glycoprotein: So Many Ways to Turn It On J. Clin. Pharmacol., March 1, 2008; 48(3): 365 - 378. [Abstract] [Full Text] [PDF]

				W. Walther, F. Arlt, I. Fichtner, J. Aumann, U. Stein, and P. M. Schlag Heat-inducible in vivo gene therapy of colon carcinoma by human mdr1 promoter-regulated tumor necrosis factor-{alpha} expression Mol. Cancer Ther., January 1, 2007; 6(1): 236 - 243. [Abstract] [Full Text] [PDF]

				B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System. Physiol Rev, October 1, 2006; 86(4): 1179 - 1236. [Abstract] [Full Text] [PDF]

				B. Wang, S. Ngoi, J. Wang, S. S. Chong, and C. G. L. Lee The Promoter Region of the MDR1 Gene Is Largely Invariant, but Different Single Nucleotide Polymorphism Haplotypes Affect MDR1 Promoter Activity Differently in Different Cell Lines Mol. Pharmacol., July 1, 2006; 70(1): 267 - 276. [Abstract] [Full Text] [PDF]

				T. Tchenio, M. Havard, L. A. Martinez, and F. Dautry Heat Shock-Independent Induction of Multidrug Resistance by Heat Shock Factor 1 Mol. Cell. Biol., January 15, 2006; 26(2): 580 - 591. [Abstract] [Full Text] [PDF]

				M. Kuwano, Y. Oda, H. Izumi, S.-J. Yang, T. Uchiumi, Y. Iwamoto, M. Toi, T. Fujii, H. Yamana, H. Kinoshita, et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance Mol. Cancer Ther., November 1, 2004; 3(11): 1485 - 1492. [Abstract] [Full Text] [PDF]

				C. Aleman, J.-P. Annereau, X.-J. Liang, C. O. Cardarelli, B. Taylor, J. J. Yin, A. Aszalos, and M. M. Gottesman P-Glycoprotein, Expressed in Multidrug Resistant Cells, Is Not Responsible for Alterations in Membrane Fluidity or Membrane Potential Cancer Res., June 15, 2003; 63(12): 3084 - 3091. [Abstract] [Full Text] [PDF]

				E. Yague, A. L. Armesilla, G. Harrison, J. Elliott, A. Sardini, C. F. Higgins, and S. Raguz P-glycoprotein (MDR1) Expression in Leukemic Cells Is Regulated at Two Distinct Steps, mRNA Stabilization and Translational Initiation J. Biol. Chem., March 14, 2003; 278(12): 10344 - 10352. [Abstract] [Full Text] [PDF]

				Z. He, W.-Y. Ma, G. Liu, Y. Zhang, A. M. Bode, and Z. Dong Arsenite-induced Phosphorylation of Histone H3 at Serine 10 Is Mediated by Akt1, Extracellular Signal-regulated Kinase 2, and p90 Ribosomal S6 Kinase 2 but Not Mitogen- and Stress-activated Protein Kinase 1 J. Biol. Chem., March 14, 2003; 278(12): 10588 - 10593. [Abstract] [Full Text] [PDF]

				U. Stein, K. Jurchott, M. Schlafke, and P. Hohenberger Expression of Multidrug Resistance Genes MVP, MDR1, and MRP1 Determined Sequentially Before, During, and After Hyperthermic Isolated Limb Perfusion of Soft Tissue Sarcoma and Melanoma Patients J. Clin. Oncol., August 1, 2002; 20(15): 3282 - 3292. [Abstract] [Full Text] [PDF]

				J.-M. Yang, A. D. Vassil, and W. N. Hait Activation of Phospholipase C Induces the Expression of the Multidrug Resistance (MDR1) Gene through the Raf-MAPK Pathway Mol. Pharmacol., October 1, 2001; 60(4): 674 - 680. [Abstract] [Full Text] [PDF]

				J. Liu, H. Chen, D. S. Miller, J. E. Saavedra, L. K. Keefer, D. R. Johnson, C. D. Klaassen, and M. P. Waalkes Overexpression of Glutathione S-Transferase II and Multidrug Resistance Transport Proteins Is Associated with Acquired Tolerance to Inorganic Arsenic Mol. Pharmacol., August 1, 2001; 60(2): 302 - 309. [Abstract] [Full Text] [PDF]

				K. W. Scotto and R. A. Johnson Transcription of MDR1: A Therapeutic Target Mol. Interv., June 1, 2001; 1(2): 117 - 125. [Abstract] [Full Text] [PDF]

				J. Albertus and R. Laine Enhanced xenobiotic transporter expression in normal teleost hepatocytes: response to environmental and chemotherapeutic toxins J. Exp. Biol., January 1, 2001; 204(2): 217 - 227. [Abstract] [PDF]

				Z. Hu, S. Jin, and K. W. Scotto Transcriptional Activation of the MDR1 Gene by UV Irradiation. ROLE OF NF-Y AND Sp1 J. Biol. Chem., January 28, 2000; 275(4): 2979 - 2985. [Abstract] [Full Text] [PDF]

				F. Thevenod, J. M. Friedmann, A. D. Katsen, and I. A. Hauser Up-regulation of Multidrug Resistance P-glycoprotein via Nuclear Factor-kappa B Activation Protects Kidney Proximal Tubule Cells from Cadmium- and Reactive Oxygen Species-induced Apoptosis J. Biol. Chem., January 21, 2000; 275(3): 1887 - 1896. [Abstract] [Full Text] [PDF]

				X. F. Hu, A. Slater, P. Kantharidis, D. Rischin, S. Juneja, R. Rossi, G. Lee, J. D. Parkin, and J. R. Zalcberg Altered Multidrug Resistance Phenotype Caused by Anthracycline Analogues and Cytosine Arabinoside in Myeloid Leukemia Blood, June 15, 1999; 93(12): 4086 - 4095. [Abstract] [Full Text] [PDF]

				W. M. Toone, S. Kuge, M. Samuels, B. A. Morgan, T. Toda, and N. Jones Regulation of the fission yeast transcription factor Pap1 by oxidative stress: requirement for the nuclear export factor Crm1 (Exportin) and the stress-activated MAP kinase Sty1/Spc1 Genes & Dev., May 15, 1998; 12(10): 1453 - 1463. [Abstract] [Full Text]

				A. Lau, S. Nightingale, G. P. Taylor, T. W. Gant, and A. J. Cann Enhanced MDR1 Gene Expression in Human T-Cell Leukemia Virus-I-Infected Patients Offers New Prospects for Therapy Blood, April 1, 1998; 91(7): 2467 - 2474. [Abstract] [Full Text] [PDF]

				C. R. Sussman and J. L. Renfro Heat shock-induced protection and enhancement of Na+-glucose cotransport by LLC-PK1 monolayers Am J Physiol Renal Physiol, October 1, 1997; 273(4): F530 - F537. [Abstract] [Full Text] [PDF]

				C. Q. Zhao, M. R. Young, B. A. Diwan, T. P. Coogan, and M. P. Waalkes Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression PNAS, September 30, 1997; 94(20): 10907 - 10912. [Abstract] [Full Text] [PDF]

				G. Zhou and M. T. Kuo NF-kappa B-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells J. Biol. Chem., June 13, 1997; 272(24): 15174 - 15183. [Abstract] [Full Text] [PDF]

				R. Sundseth, G. Macdonald, J. Ting, and A. C. King DNA Elements Recognizing NF-Y and Sp1 Regulate the Human Multidrug-Resistance Gene Promoter Mol. Pharmacol., June 1, 1997; 51(6): 963 - 971. [Abstract] [Full Text]

				M. T. Osborn and T. C. Chambers Role of the Stress-activated/c-Jun NH2-terminal Protein Kinase Pathway in the Cellular Response to Adriamycin and Other Chemotherapeutic Drugs J. Biol. Chem., November 29, 1996; 271(48): 30950 - 30955. [Abstract] [Full Text] [PDF]

				T. Ishikawa, J.-J. Bao, Y. Yamane, K. Akimaru, K. Frindrich, C. D. Wright, and M. T. Kuo Coordinated Induction of MRP/GS-X Pump and gamma -Glutamylcysteine Synthetase by Heavy Metals in Human Leukemia Cells J. Biol. Chem., June 21, 1996; 271(25): 14981 - 14988. [Abstract] [Full Text] [PDF]

				H Kusaba, K Kohno, K Asakuno, M Kuwano, K Okumura, E D Green, D Schlessinger, and M Wada Functional expression of yeast artificial chromosome-human multidrug resistance genes in mouse cells. Genome Res., October 1, 1995; 5(3): 245 - 258. [Abstract] [PDF]

				M. E. Goldsmith, J. M. Gudas, E. Schneider, and K. H. Cowan Wild Type p53 Stimulates Expression from the Human Multidrug Resistance Promoter in a p53-negative Cell Line J. Biol. Chem., January 27, 1995; 270(4): 1894 - 1898. [Abstract] [Full Text] [PDF]

				C.H. Lee, G. Bradley, and V. Ling Expression of P-Glycoprotein in Normal and Malignant Rat Liver Cells Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 607 - 615. [Abstract] [PDF]

				K. Chin, K Ueda, I Pastan, and M. Gottesman Modulation of activity of the promoter of the human MDR1 gene by Ras and p53 Science, January 24, 1992; 255(5043): 459 - 462. [Abstract] [PDF]

				U. Stein, K. Jurchott, W. Walther, S. Bergmann, P. M. Schlag, and H.-D. Royer Hyperthermia-induced Nuclear Translocation of Transcription Factor YB-1 Leads to Enhanced Expression of Multidrug Resistance-related ABC Transporters J. Biol. Chem., July 20, 2001; 276(30): 28562 - 28569. [Abstract] [Full Text] [PDF]

				N. E. Vilaboa, A. Galan, A. Troyano, E. de Blas, and P. Aller Regulation of Multidrug Resistance 1 (MDR1)/P-glycoprotein Gene Expression and Activity by Heat-Shock Transcription Factor 1 (HSF1) J. Biol. Chem., August 4, 2000; 275(32): 24970 - 24976. [Abstract] [Full Text] [PDF]

				C.-H. Wang, J.-S. Jeng, P.-K. Yip, C.-L. Chen, L.-I Hsu, Y.-M. Hsueh, H.-Y. Chiou, M.-M. Wu, and C.-J. Chen Biological Gradient Between Long-Term Arsenic Exposure and Carotid Atherosclerosis Circulation, April 16, 2002; 105(15): 1804 - 1809. [Abstract] [Full Text] [PDF]